Baader Bank Aktiengesellschaft Purchases 154,582 Shares of Tilray Inc (NASDAQ:TLRY)

Baader Bank Aktiengesellschaft raised its stake in Tilray Inc (NASDAQ:TLRY) by 103.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 304,582 shares of the company’s stock after purchasing an additional 154,582 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Tilray were worth $504,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vontobel Holding Ltd. grew its stake in Tilray by 2.7% in the fourth quarter. Vontobel Holding Ltd. now owns 278,199 shares of the company’s stock valued at $640,000 after purchasing an additional 7,362 shares during the last quarter. International Assets Investment Management LLC grew its stake in shares of Tilray by 179.0% during the fourth quarter. International Assets Investment Management LLC now owns 14,734 shares of the company’s stock worth $34,000 after acquiring an additional 9,453 shares during the last quarter. CapWealth Advisors LLC grew its stake in shares of Tilray by 12.5% during the first quarter. CapWealth Advisors LLC now owns 90,000 shares of the company’s stock worth $222,000 after acquiring an additional 10,000 shares during the last quarter. Simplicity Wealth LLC purchased a new stake in shares of Tilray during the first quarter worth about $28,000. Finally, RPO LLC purchased a new stake in shares of Tilray during the fourth quarter worth about $28,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Stock Up 1.6 %

Shares of TLRY stock traded up $0.03 during trading hours on Thursday, reaching $1.95. 19,436,513 shares of the company’s stock were exchanged, compared to its average volume of 25,872,123. Tilray Inc has a 1 year low of $1.50 and a 1 year high of $3.40. The stock has a market cap of $1.64 billion, a PE ratio of -4.49 and a beta of 2.19. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The stock’s fifty day moving average price is $1.79 and its two-hundred day moving average price is $1.88.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. During the same quarter in the previous year, the firm posted ($0.15) EPS. Tilray’s revenue was up 24.8% on a year-over-year basis. Research analysts predict that Tilray Inc will post -0.12 EPS for the current year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.